Ikarian Capital’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-175,088
Closed -$214K 159
2025
Q1
$214K Hold
175,088
0.03% 95
2024
Q4
$315K Sell
175,088
-12
-0% -$22 0.04% 96
2024
Q3
$891K Buy
175,100
+75,100
+75% +$382K 0.12% 57
2024
Q2
$711K Buy
+100,000
New +$711K 0.12% 61